DBV Technologies(DBVT) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Press Release DBV Announces Positive Regulatory Updates for the Viaskin® Peanut Patch in the United States and Europe • DBV to pursue an Accelerated Approval pathway for toddlers ages 1 – 3 years-old • BLA submission under Accelerated Approval is subject to completion of a six-month supplemental safety study in toddlers to be initiated in Q2 2025 • VITESSE Phase 3 study evaluating the Viaskin Peanut patch in children ages 4 – 7 years-old exceeded enrollment goals; Topline results on track for 4 ...